Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan

BACKGROUND/AIMS: 5-Aminosalicylic acid (5-ASA) is a basic drug for inducing and maintaining remission for ulcerative colitis. One of its formulations has a coating with a pH-dependent degradation that ensures the release 5-ASA at the terminal ileum. No evidence has been shown concerning the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimodaira, Yosuke, Onochi, Kengo, Watanabe, Kenta, Takahashi, So, Fukuda, Sho, Watanabe, Noboru, Koizumi, Shigeto, Matsuhashi, Tamotsu, Iijima, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100376/
https://www.ncbi.nlm.nih.gov/pubmed/32806877
http://dx.doi.org/10.5217/ir.2020.00023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100376/
https://www.ncbi.nlm.nih.gov/pubmed/32806877
http://dx.doi.org/10.5217/ir.2020.00023

Ejemplares similares